1. Home
  2. CPIX vs GROW Comparison

CPIX vs GROW Comparison

Compare CPIX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.91

Market Cap

34.1M

Sector

Health Care

ML Signal

N/A

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

N/A

Current Price

$2.36

Market Cap

32.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
GROW
Founded
1999
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
32.2M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
GROW
Price
$3.91
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
173.2K
43.8K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
3.75%
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$41,278,349.00
$8,546,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$36.81
Revenue Growth
12.21
N/A
52 Week Low
$1.85
$2.02
52 Week High
$7.25
$2.78

Technical Indicators

Market Signals
Indicator
CPIX
GROW
Relative Strength Index (RSI) 80.29 46.23
Support Level $2.42 $2.36
Resistance Level $2.73 $2.50
Average True Range (ATR) 0.34 0.07
MACD 0.20 -0.00
Stochastic Oscillator 91.45 27.97

Price Performance

Historical Comparison
CPIX
GROW

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

Share on Social Networks: